Sec Form 13G Filing - Lance Friedman filing for Aspire BioPharma, Inc. (ASBP) - 2025-04-17

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Includes 1,680,886 shares of common stock held by Blackstone Capital Advisors, Inc., 1,708,347 share of common stock held by Cobra Alternative Strategies LLC, and 662,500 shares of common stock held by Thor Special Situations LLC.


SCHEDULE 13G


 
Lance Friedman
 
Signature:/s/ Lance Friedman
Name/Title:Lance Friedman
Date:04/17/2025
primary_doc.xml